Search
for
Sort by
Research 30 of 644
- Association between hair loss and cardiometabolic diseases in Chinese adults: a cross-sectional analysis in Tianning Cohort
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Long COVID syndrome: An unfolding enigma
- Polycystic ovary syndrome
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Rare and common genetic determinants of metabolic individuality and their effects on human health
- The Roles of EDA2R in Ageing and Disease
- Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
- Cardiometabolic profile of young women with hypoprolactinemia
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Interval training and cardiometabolic health in reproductive-aged females
- Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis
- Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Cardiometabolic comorbidities associated with androgenetic alopecia: Findings from a sex-stratified, propensity-matched national cohort
- Repurposing of Drugs for Cardiometabolic Disorders: An Out and Out Cumulation
- PCOS and Cardiometabolic Health over the Reproductive Years
- A Multidisciplinary Lifestyle Intervention for Women with Polycystic Ovary Syndrome: The Role of a Pulse-Based Diet and Aerobic Exercise on Reproductive, Cardio-Metabolic, and Quality of Life Outcomes
- Cardiometabolic aspects of the polycystic ovary syndrome
- Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome
- Impaired Cardiometabolic Effects of Bromocriptine in Men With Early‐Onset Androgenic Alopecia
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Impact of lisinopril on cardiometabolic risk factors in men with hypertension and early-onset androgenetic alopecia
- Anabolic-Androgenic Steroids and Cardiometabolic Derangements
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications